When medical innovation happens, the whole world benefits! Vx Pharma is a privately owned clinical research ‘super-site’ in South Africa that provides comprehensive solutions for phase 1 to 4 clinical trials. Two dedicated research businesses and an impressive network of collaborators enable us to offer a first-class service from patient recruitment to drug evaluation, including in- and outpatient facilities and an on-site clinical diagnostics laboratory. The main focus of Vx Pharma is delivering quality turnkey services that provide end-to-end solutions to our pharma, biotech and CRO clients.
The founders of Vx Pharma, Dr Mark Fyvie, Dr Gil Mahlati and Dr Paul Abrahams, all have academic and professional backgrounds in leading global institutions and companies. As one of few BBBEE service providers, we take pride in participating in South Africa’s clinical development outsourcing market through two major service offerings: Clinical Diagnostics Services and Clinical Trial Services.
Vx Pharma aims to be South Africa’s leading BBBEE-accredited, clinical trials business that owns and operates its own research sites dedicated to offering end-to-end turnkey solutions, including clinical diagnostics, to help the global healthcare industry improve medical knowledge and bring better health to the world.